Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...

Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond ...

Elevance Health Inc. (ELV) released a profit for fourth quarter that decreased from last year The company's bottom line totaled $418 ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...